LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

PROCEPT BioRobotics Corp

Closed

SectorHealthcare

64.72 5.17

Overview

Share price change

24h

Current

Min

60.95

Max

66.69

Key metrics

By Trading Economics

Income

-5.9M

-25M

Sales

926K

69M

EPS

-0.45

Profit margin

-35.767

Employees

756

EBITDA

-6M

-22M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+33.71% upside

Dividends

By Dow Jones

Next Earnings

31 Jul 2025

Market Stats

By TradingEconomics

Market Cap

237M

3.2B

Previous open

59.55

Previous close

64.72

News Sentiment

By Acuity

40%

60%

141 / 380 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

PROCEPT BioRobotics Corp Chart

Past performance is not a reliable indicator of future results.

Related News

28 Oct 2024, 14:42 UTC

Earnings

These Stocks Are Moving the Most Today: Boeing, APA, Ford, Nvidia, Philips, ON Semi, McDonald's, Procept BioRobotics, and More -- Barrons.com

Peer Comparison

Price change

PROCEPT BioRobotics Corp Forecast

Price Target

By TipRanks

33.71% upside

12 Months Forecast

Average 80.2 USD  33.71%

High 90 USD

Low 71 USD

Based on 10 Wall Street analysts offering 12 month price targets forPROCEPT BioRobotics Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

8

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

52.655 / 56.31Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

141 / 380 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.